欧博ABG官网-欧博官方网址-会员登入

The FDA announced a nationwide recall of over 140,000 bottles of Atorvastatin Calcium tablets.

The recall includes multiple dosages and lot numbers of the generic cholesterol medication.

Consumers are advised to check their medication bottles and contact their healthcare provider or pharmacy for guidance.

More than 140,000 bottles of a prescription cholesterol medication have been recalled due to "failed dissolution specifications," the Food and Drug Administration announced earlier this month.

Ascend Laboratories of New Jersey recalled certain bottles of Atorvastatin Calcium tablets, a generic version of Lipitor, sold nationwide. The recall was announced on Sept. 19 and given a Class II risk level on Oct. 10.

The Class II classification indicates that the recalled medication "may cause temporary or medically reversible adverse health consequences," but the risk of serious health consequences is low.

Identifying the Recalled Medication

The recall affects at least 141,984 bottles of Atorvastatin Calcium tablets, a type of statin used to lower the amount of cholesterol in a person's blood to prevent stroke, heart attack, and chest pain.

See the entire list of recalled medications below, including dosages, bottle sizes, and expiration dates:

Product Description   Bottle Size   Lot Numbers   Expiration Dates  
Atorvastatin Calcium Tablets USP, 10 mg   90-count, 500-count, and 1000-count bottles   25141249, 24144938, 24144868, 24144867, 24144458, 24143994, 24142987, 24143316,   Feb. 2027, Nov. 2026, Sep. 2026, July 2026  
Atorvastatin Calcium Tablets USP, 40 mg   90-count, 500-count, and 1000-count bottles    25140933, 25140477, 24144254, 24144163, 24143995   Feb. 2027, Dec. 2026, Oct. 2026, Sep. 2026,  
Atorvastatin Calcium Tablets USP, 20 mg   90-count, 500-count, and 1000-count bottles   25140150, 25140173, 25140172, 24144720, 24144798, 24144692, 24143755, 24143913, 24143754, 24143047, 24142936   Dec. 2026, Nov. 2026, Oct. 2026, Aug. 2026, June 2026, July 2026  
Atorvastatin Calcium Tablets USP, 80 mg   90-count and 500-count bottles   25140249, 25140247, 24144999, 24144942, 24144845, 24144713, 24144652, 24143898, 24143412, 24143582   Dec. 2026, Nov. 2026, Oct. 2026, Aug. 2026,  

Ascent Laboratories recalled the medication due to "failed dissolution specifications," meaning the drug did not dissolve as expected in laboratory settings, which could make it less effective.

What You Should Do

The recalling firm did not issue a press release for this recall, so there are no specific instructions for medications users.

Your best bet is to check your medications at home, and if you have any bottles affected by the recall, don't take them. Instead, call your healthcare provider or a pharmacy for a replacement bottle or a refund.

Edited by

Health with a background in health, science, and investigative reporting. Previously, she wrote full time about parenting issues for the app Parent Lab. Before that, she worked as a reporter for National Geographic covering wildlife crime and exploitation." tabindex="0" data-inline-tooltip="true"> Jani Hall

Jani Hall

Jani Hall is a news editor for Health with a background in health, science, and investigative reporting. Previously, she wrote full time about parenting issues for the app Parent Lab. Before that, she worked as a reporter for National Geographic covering wildlife crime and exploitation.

learn more

Read more:

Was this page helpful?

Thanks for your feedback!

Tell us why!

Other

2 Sources

Health.com uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

Food and Drug Administration. .

National Cancer Institute. Atorvastatin calcium.